Omega Healthcare Investors, Inc. (NYSE:OHI) Receives Consensus Recommendation of “Hold” from Brokerages

Omega Healthcare Investors, Inc. (NYSE:OHI) has been given a consensus recommendation of “Hold” by the fifteen research firms that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $48.50.

OHI has been the topic of several recent research reports. Wells Fargo & Company boosted their price objective on shares of Omega Healthcare Investors from $47.00 to $49.00 and gave the stock an “equal weight” rating in a research report on Monday, June 1st. Weiss Ratings upgraded shares of Omega Healthcare Investors from a “buy (b)” rating to a “buy (b+)” rating in a report on Tuesday, June 30th. Barclays began coverage on shares of Omega Healthcare Investors in a research report on Tuesday. They set an “underweight” rating and a $51.00 target price for the company. Scotiabank reduced their price target on shares of Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating on the stock in a report on Thursday, June 18th. Finally, Truist Financial lowered their price target on shares of Omega Healthcare Investors from $48.00 to $46.00 and set a “hold” rating on the stock in a research report on Tuesday, June 9th.

Omega Healthcare Investors Price Performance

NYSE:OHI traded up $1.03 during trading hours on Thursday, hitting $50.05. The company’s stock had a trading volume of 193,343 shares, compared to its average volume of 2,162,735. Omega Healthcare Investors has a 52-week low of $35.70 and a 52-week high of $50.03. The company has a debt-to-equity ratio of 0.81, a quick ratio of 5.32 and a current ratio of 5.32. The business’s 50-day moving average is $46.75 and its two-hundred day moving average is $45.93. The company has a market capitalization of $14.90 billion, a PE ratio of 24.19, a PEG ratio of 2.10 and a beta of 0.58.

Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.02). Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The company had revenue of $322.95 million during the quarter, compared to analysts’ expectations of $264.07 million. During the same period last year, the business posted $0.75 earnings per share. The company’s quarterly revenue was up 16.7% on a year-over-year basis. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. As a group, research analysts anticipate that Omega Healthcare Investors will post 3.1 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, May 4th were paid a $0.67 dividend. The ex-dividend date of this dividend was Monday, May 4th. This represents a $2.68 dividend on an annualized basis and a yield of 5.4%. Omega Healthcare Investors’s dividend payout ratio is presently 129.47%.

Institutional Trading of Omega Healthcare Investors

Several institutional investors and hedge funds have recently made changes to their positions in OHI. State Street Corp increased its position in Omega Healthcare Investors by 4.8% during the 2nd quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock worth $534,792,000 after purchasing an additional 671,473 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Omega Healthcare Investors by 9.4% during the 4th quarter. Geode Capital Management LLC now owns 8,515,924 shares of the real estate investment trust’s stock worth $377,648,000 after purchasing an additional 734,774 shares during the last quarter. Invesco Ltd. boosted its stake in shares of Omega Healthcare Investors by 8.6% during the 4th quarter. Invesco Ltd. now owns 5,368,945 shares of the real estate investment trust’s stock worth $238,059,000 after purchasing an additional 424,024 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Omega Healthcare Investors by 4.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,463,838 shares of the real estate investment trust’s stock worth $197,927,000 after buying an additional 174,062 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of Omega Healthcare Investors by 18.5% during the fourth quarter. Bank of New York Mellon Corp now owns 4,457,975 shares of the real estate investment trust’s stock worth $197,667,000 after buying an additional 696,759 shares in the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.